by MM360 Staff | May 14, 2025 | Uncategorized
Source: CureToday articles The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases. Read More
by MM360 Staff | May 13, 2025 | Uncategorized
Source: CureToday articles After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now. Read More
by MM360 Staff | May 13, 2025 | Uncategorized
Source: CureToday articles Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence. Read More
by MM360 Staff | May 13, 2025 | Uncategorized
Source: CureToday articles Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease. Read More
by MM360 Staff | May 13, 2025 | Uncategorized
Source: CureToday articles I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality. Read More
by MM360 Staff | May 13, 2025 | Uncategorized
Source: CureToday articles Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, eliciting a strong immune response. Read More